Later Lines of Therapy for Metastatic Colorectal Cancer

Video

Transcript:

Tanios Bekaii-Saab, MD: Almost 90% or more of patients who progressed through first-line therapy will make it to the second line. Second-line options will depend on what you

Related Videos
Pashtoon Murtaza Kasi, MD, MS
Michael Iglesia, MD, PhD
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Jin Qian, PhD
A panel of 4 experts on colorectal cancer
Heinz-Josef Lenz, MD, FACP
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Michael Iglesia, MD, PhD
Kian-Huat Lim, MD, PhD